Skorpian links to the following
article; it deals with TB, IGRA and dialysis patients and gets straight to the point
current strategy in dialysis patients should use these tests instead of TST for LTBI screening and as an aid for the diagnosis of active TB.
The article was printed by the
American Society of Nephrology which, according to
sources, is
the world’s largest professional society devoted to the study of kidney disease. Composed of 11,000 physicians and scientists, ASN promotes expert patient care, advances medical research, and educates the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients.
It is worth reflecting on what Lodge Partners said back in February 2010
The company has also developed an impressive network of global key opinion leaders, who have not only been able to assist in the design and evaluation of the test but will also be critical in building demand for the product
